Goodman Capital logo

Goodman Capital

Asia, Central Region, Singapore, Singapore

Description

Private investment firm investing in technology and biotech companies across USA and Asia from early-stage to pre-IPO

Investor Profile

Goodman Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • Singapore (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Goodman Capital frequently co-invest with?

Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 2
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Vectr
Asia, Hong Kong Island, Hong Kong, Sheung Wan
Co-Investments: 1
Nest.Bio Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
WI Harper Group
North America, California, United States, San Francisco
Co-Investments: 2
DHVC
North America, California, United States, Palo Alto
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Goodman Capital?

Engine Biosciences

Singapore, Central Region, Singapore

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine Learning
Series AMay 26, 2021
Amount Raised: $43,000,000
Senti Biosciences

South San Francisco, California, United States

Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.

BiotechnologyHealth CareMedicalTherapeutics
Series AFeb 27, 2018
Amount Raised: $53,000,000
Engine Biosciences

Singapore, Central Region, Singapore

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine Learning
SeedJan 31, 2018
Amount Raised: $10,000,000